Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Solid Biosciences
SLDB
$849M
| $330K | ﹤0.01% |
82,493
+9,281
| +13% | +$51K |
|
3002
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.91B
| $329K | ﹤0.01% |
+3,523
| New | +$336K |
|
3003
Ohio Valley Banc Corp
OVBC
$202M
| $329K | ﹤0.01% |
13,575
-400
| -3% | -$10K |
|
3004
Inuvo
INUV
$18M
| $328K | ﹤0.01% |
50,715
+4,335
| +9% | +$12.6K |
|
3005
Mativ Holdings
MATV
$507M
| $326K | ﹤0.01% |
+29,912
| New | +$417K |
|
3006
Apyx Medical
APYX
$180M
| $326K | ﹤0.01% |
206,195
+2,900
| +1% | +$4.06K |
|
3007
iShares Core MSCI Total International Stock ETF
IXUS
$59.6B
| $324K | ﹤0.01% |
+4,900
| New | +$340K |
|
3008
First Trust RBA American Industrial Renaissance ETF
AIRR
$10.6B
| $324K | ﹤0.01% |
+4,200
| New | +$335K |
|
|
CMBM
3009
DELISTED
Cambium Networks
CMBM
| $324K | ﹤0.01% |
501,800
+363,399
| +263% | +$428K |
|
3010
State Street SPDR S&P Semiconductor ETF
XSD
$2.93B
| $323K | ﹤0.01% |
1,300
-1,100
| -46% | -$270K |
|
3011
Zura Bio
ZURA
$541M
| $323K | ﹤0.01% |
129,114
+65,214
| +102% | +$232K |
|
3012
TTEC Holdings
TTEC
$132M
| $321K | ﹤0.01% |
64,322
+49,600
| +337% | +$259K |
|
|
ACCS
3013
ACCESS Newswire
ACCS
$25.8M
| $319K | ﹤0.01% |
35,738
+300
| +0.8% | +$2.98K |
|
3014
Intellicheck
IDN
$78.6M
| $319K | ﹤0.01% |
114,000
+9,900
| +10% | +$24.9K |
|
|
WW
3015
DELISTED
WW International
WW
| $319K | ﹤0.01% |
+250,838
| New | +$301K |
|
|
SPYU
3016
MAX S&P 500 4x Leveraged ETN
SPYU
$292M
| $318K | ﹤0.01% |
+13,600
| New | +$338K |
|
|
GB
3017
DELISTED
Global Blue Group Holding
GB
| $317K | ﹤0.01% |
45,800
+19,600
| +75% | +$113K |
|
3018
Accenture
ACN
$104B
| $317K | ﹤0.01% |
+900
| New | +$324K |
|
3019
PJT Partners
PJT
$4.38B
| $316K | ﹤0.01% |
+2,000
| New | +$305K |
|
3020
Jerash Holdings
JRSH
$61.7M
| $315K | ﹤0.01% |
92,240
+19,800
| +27% | +$63.5K |
|
3021
Live Ventures
LIVE
$29M
| $315K | ﹤0.01% |
33,799
-2,070
| -6% | -$22.3K |
|
3022
Virtus Investment Partners
VRTS
$1.11B
| $315K | ﹤0.01% |
1,429
-3,372
| -70% | -$768K |
|
3023
Ebang International Holdings
EBON
$11.7M
| $315K | ﹤0.01% |
55,027
+8,414
| +18% | +$58.2K |
|
3024
BTCS Inc
BTCS
$53.3M
| $315K | ﹤0.01% |
127,391
+90,171
| +242% | +$214K |
|
|
ZBIO
3025
Zenas BioPharma
ZBIO
$1.98B
| $314K | ﹤0.01% |
+38,400
| New | +$599K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.